UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Topoisomerase I in the Era of Precision Medicine

Clinical cancer research, 2019-11, Vol.25 (22), p.6581-6589

2019

Volltextzugriff (PDF)

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

Journal of hypertension, 2003-05, Vol.21 (5), p.875-886

2003

Volltextzugriff (PDF)

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.77-85

2009

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

The New England journal of medicine, 2014-04, Vol.370 (16), p.1483-1493

2014

Volltextzugriff (PDF)

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Circulation (New York, N.Y.), 2015-01, Vol.131 (2), p.157-164

2015

Volltextzugriff (PDF)

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder

Annals of neurology, 2020-03, Vol.87 (3), p.347-356

2020

Volltextzugriff (PDF)

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

The Lancet infectious diseases, 2017-10, Vol.17 (10), p.1062-1068

2017

Volltextzugriff (PDF)

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

Drug metabolism and disposition, 2015-09, Vol.43 (9), p.1360-1371

2015

Volltextzugriff (PDF)

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.738-746

2012

Volltextzugriff (PDF)

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1131-1140.e5

2016

Volltextzugriff (PDF)

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

The Lancet (British edition), 2010-09, Vol.376 (9745), p.975-983

2010

Volltextzugriff (PDF)

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Clinical cancer research, 2021-05, Vol.27 (10), p.2723-2733

2021

Volltextzugriff (PDF)

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

The Lancet (British edition), 2008-08, Vol.372 (9638), p.547-553

2008

Volltextzugriff (PDF)

Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

Leukemia, 2020-11, Vol.34 (11), p.2903-2913

2020

Volltextzugriff (PDF)

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with Isolated systolic hypertension: The Study on Cognition and Prognosis in the Elderly (SCOPE)

Journal of the American College of Cardiology, 2004-09, Vol.44 (6), p.1175-1180

2004

Volltextzugriff (PDF)

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Stroke (1970), 2013-06, Vol.44 (6), p.1676-1681

2013

Volltextzugriff (PDF)

Glasdegib: First Global Approval

Drugs (New York, N.Y.), 2019-02, Vol.79 (2), p.207-213

Hoy, Sheridan M.

2019

Volltextzugriff (PDF)

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (6), p.544-563

2015

Volltextzugriff (PDF)

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1405-1411

2016

Volltextzugriff (PDF)

Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML

Journal of clinical oncology, 2024-05, Vol.42 (15), p.1776-1787

2024

Volltextzugriff (PDF)

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Clinical cancer research, 2024-05, Vol.30 (10), p.2048-2056

2024

Volltextzugriff (PDF)

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)

The American heart journal, 2012-06, Vol.163 (6), p.931-937.e1

2012

Volltextzugriff (PDF)

New drugs approved for acute myeloid leukaemia in 2018

British journal of clinical pharmacology, 2019-12, Vol.85 (12), p.2689-2693

2019

Volltextzugriff (PDF)

1 – 25 von 1.193

Suche als RSS-Feed

Aktive Filter

ThemaBenzimidazoles - Administration & Dosage

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.075)
Mit Volltextzugriff
(812)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(942)
Science & Technology
(913)
Benzimidazoles - Therapeutic Use
(906)
Life Sciences & Biomedicine
(899)
Male
(673)
Female
(645)
Middle Aged
(487)
Aged
(387)
Adult
(352)
Animals
(327)
Benzimidazoles - Adverse Effects
(307)
Treatment Outcome
(305)
Administration, Oral
(241)
Biological And Medical Sciences
(237)
Medical Sciences
(230)
Pharmacology & Pharmacy
(207)
Drug Therapy, Combination
(189)
Dabigatran
(176)
Cardiovascular System & Cardiology
(175)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting Topoisomerase I in the Era of Precision Medicine

Design of amidobenzimidazole STING receptor agonists with systemic activity

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with Isolated systolic hypertension: The Study on Cognition and Prognosis in the Elderly (SCOPE)

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Glasdegib: First Global Approval

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)

New drugs approved for acute myeloid leukaemia in 2018

Aktive Filter

Suchergebnisse filtern